Drawing for ADOPT-A-PATIENT

USPTO serial 97373687

ADOPT-A-PATIENT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BHANOT, KAPIL KUMAR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADOPT-A-PATIENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON ST, NW, SUITE 400WASHINGTON, DC 20007United States

Goods and services

ClassDescriptionStatusFirst use
035Promoting awareness of life saving blood plasma donation, blood plasma, blood conditions, blood treatment and immune deficiencies; Promoting the donation of blood plasma by means of arranging and conducting incentive reward and blood plasma donor loyalty programs, administration of an incentive reward and blood plasma donor loyalty program to promote blood plasma collection services and collection of blood plasma; Promoting public awareness of blood disorders and blood plasma and its treatment and impact on patientsACTIVE—
041Educational services, namely, conducting programs and training courses in the field of blood diseases, illnesses and conditions, as well as, awareness of blood plasma, blood plasma donations, blood treatment and immune deficiencies; Educational services, namely, providing online instruction in the field of blood plasma, blood plasma donations, blood conditions, blood treatment and immune deficiencies via an online website; Educational services, namely, providing on-line classes, seminars, conferences and workshops in the field of blood plasma, blood plasma donations, blood conditions, blood treatment and immune deficiencies and distribution of training materials in connection therewith; Educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of blood plasma, blood plasma donations, blood conditions, blood treatment and immune deficienciesACTIVE—
044Medical information services; providing medical information and medical treatment information in the field of health, blood conditions, blood plasma and blood plasma donation; health care information services; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by blood plasma, blood plasma donations, blood conditions, blood treatment and immune deficiencies; all of the foregoing excluding optometry or ophthalmology servicesACTIVE—
045Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Providing personal support services for patients and families of patients, namely, providing emotional counseling and emotional support in the field of blood plasma, blood plasma conditions and patient supportACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 22, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 22, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 17, 2026EX5GSOU EXTENSION 5 GRANTED—
Mar 13, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 15, 2025EXT5SOU EXTENSION 5 FILED—
Apr 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 16, 2025EX4GSOU EXTENSION 4 GRANTED—
Apr 16, 2025EXT4SOU EXTENSION 4 FILED—
Apr 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 21, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 16, 2024EX3GSOU EXTENSION 3 GRANTED—
Oct 16, 2024EXT3SOU EXTENSION 3 FILED—
Oct 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 16, 2024EX2GSOU EXTENSION 2 GRANTED—
Apr 16, 2024EXT2SOU EXTENSION 2 FILED—
Apr 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 18, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 16, 2023EX1GSOU EXTENSION 1 GRANTED—
Oct 16, 2023EXT1SOU EXTENSION 1 FILED—
Oct 16, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 14, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 14, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 14, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 14, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 6, 2023DOCKASSIGNED TO EXAMINER—
Apr 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 25, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance